Cambridge Epigenetix Raises $88M in Series D Funding Round - NewsBreak

NEW YORK – Cambridge Epigenetix said on Tuesday that it has raised $88 million in a Series D financing round. Singapore's Temasek led the round, joined by new investors, including Third Point, and existing investors, including GV, New...